CLINICAL_TRIALS
trial_result
· 2025-08-06
Clinical Trial Update: Efficacy And Safety Of MK-6194 In Adult Participants With Systemic Lupus Erythematosus (MK-6194-006) [Phase 2]
Summary
A Phase 2 clinical trial evaluating MK-6194 for systemic lupus erythematosus in adults has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: TERMINATED